Innate Pharma to participate in upcoming investor conferences

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming investor conferences:  

  • Stifel 2022 Healthcare Conference, New-York

Event Date: November 15-16, 2022 (in-person event)

  • Evercore ISI 5th Annual HealthConX Conference

Event Date: November 29 – December 1, 2022 (virtual)